Autopsy report · NCT00174239
Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
Cause of deathNo reason given
“See Detailed Description for termination reason.”
Life of this trial
- Registered 1 year 2 months after it had already started.
- Ran for about 1 year 2 months before it stopped.
- 220 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Parkinson Disease
- Interventions
- cabergoline; controlled-release levodopa / carbidopa
- Participants
- 220
- Sites
- 14
- Countries
- Australia, Italy, Spain
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.